Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHINE Study: Gait training with HAL after Stemirac for traumatic spinal cord injury
jRCT1030260137Not yet recruiting
- Sponsor
- Niigata National Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of milciclib in spinal cord injury (SCI), sponsored by Niigata National Hospital. Planned start May 2026; status: not yet recruiting.
02
Drugs
milciclib
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT1030260137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260137.